Sugi Predict

Sugi Predict / Compounds / Cyclamic Acid

Cyclamic Acid

Cyclamic Acid

SCHEMBL2188654

O=S(=O)([O-])NC1CCCCC1.O=S(=O)([O-])NC1CCCCC1.[Zn+2]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 3/20 0.91
▸ CA7 P43166 3/20 0.91
▸ CA14 Q9ULX7 3/20 0.91
▸ CA9 Q16790 1/20 0.91
▸ CA1 P00915 2/20 0.61
▸ CA2 P00918 1/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ RECQL P46063 1/20 0.50
▸ ALDH1A1 P00352 6/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ HTT P42858 1/20 0.46
▸ LMNA P02545 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ MEN1 O00255 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclamic Acid SCHEMBL28963281 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL692781 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL1457947 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL414415 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL1532404 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL66221 0.95 CA12 (1.00) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL4592737 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL10856451 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL9591547 0.95 CA12 (0.91) CA12CA7CA14CA9CA1
Cyclamic Acid SCHEMBL28154733 0.95 CA12 (1.00) CA12CA7CA14CA9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346342-B1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY WISCONSIN ALUMNI RES FOUND (US) 2015-09-09 — — EP claimed
US-8771772-B2 Method to separate lipids from cheese whey WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-07-08 — — US claimed
US-20130316052-A1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-11-28 — — US claimed
US-20130129889-A1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2013-05-23 — — US claimed
EP-2346342-A1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY Wisconsin Alumni Research Foundation (US) 2011-07-27 — — EP claimed
WO-2010042307-A1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-04-15 — — WO claimed
US-20100086657-A1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY FIRST-CITIZENS BANK & TRUST COMPANY 2010-04-08 — — US claimed
JP-2006502081-A — — 2006-01-19 — — JP claimed
CN-1688298-A Composition, Synthesis and Therapeutic Use of Polyamines MURPHY MICHAEL A (US) 2005-10-26 — — CN claimed
US-20050085555-A1 Composition, synthesis and therapeutic applications of polyamines MURPHY, MICHAEL A. 2005-04-21 — — US claimed
EP-1465611-A2 COMPOSITION, SYNTHESIS AND THERAPEUTIC APPLICATIONS OF POLYAMINES Murphy, Michael A. (US) 2004-10-13 — — EP claimed
WO-2003051348-A2 COMPOSITION, SYNTHESIS AND THERAPEUTIC APPLICATIONS OF POLYAMINES MURPHY MICHAEL A (US) 2003-06-26 — — WO claimed
US-20030013772-A1 Composition, synthesis and therapeutic applications of polyamines MURPHY, MICHAEL A. 2003-01-16 — — US claimed
US-4478926-A STABILIZERS ANDREWS PAPER & CHEMICAL CO., INC. (US) 1984-10-23 — — US claimed
EP-2346342-B1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY WISCONSIN ALUMNI RES FOUND (US) 2015-09-09 — — EP disclosed
US-8771772-B2 Method to separate lipids from cheese whey WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-07-08 — — US disclosed
US-8734878-B2 Method to separate lipids from cheese whey WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2014-05-27 — — US disclosed
WO-2010042307-A1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2010-04-15 — — WO disclosed
US-20100086657-A1 METHOD TO SEPARATE LIPIDS FROM CHEESE WHEY AND FAT-FREE WHEY PROTEIN PRODUCT FORMED THEREBY FIRST-CITIZENS BANK & TRUST COMPANY 2010-04-08 — — US disclosed
US-4478926-A STABILIZERS ANDREWS PAPER & CHEMICAL CO., INC. (US) 1984-10-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013772-A1 Composition, synthesis and therapeutic applications of polyamines TXN2, PYCR1, SQOR CA12 324/4885CA7 2899/4885CA14 1354/4885
US-20050085555-A1 Composition, synthesis and therapeutic applications of polyamines PRDX5, PINK1, ARG2 CA12 4712/4885CA7 4826/4885CA14 4818/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.